(5E)-3-(4-Chlorophenyl)-5-{[(4-chlorophenyl)amino]methylidene}-4-oxo-1,3-thiazolidin-1-ium-1-olate

Catalog No. :
ACIEFF736
CAS No. :
338752-82-2
Molecular Formula :
C16H12Cl2N2O2S
Molecular Weight :
367.26

IUPAC Name:(E)-3-(4-chlorophenyl)-5-(((4-chlorophenyl)amino)methylene)thiazolidin-4-one 1-oxide

(5E)-3-(4-Chlorophenyl)-5-{[(4-chlorophenyl)amino]methylidene}-4-oxo-1,3-thiazolidin-1-ium-1-olate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5E)-3-(4-Chlorophenyl)-5-{[(4-chlorophenyl)amino]methylidene}-4-oxo-1,3-thiazolidin-1-ium-1-olate
IUPAC Name(E)-3-(4-chlorophenyl)-5-(((4-chlorophenyl)amino)methylene)thiazolidin-4-one 1-oxide
MDL No.MFCD00151414
Molecular FormulaC16H12Cl2N2O2S
Molecular Weight367.26
SMILES[O-][S+]1CN(C2=CC=C(Cl)C=C2)C(/C1=C\NC3=CC=C(Cl)C=C3)=O
InChI KeyYWLGNKACSYFCGI-OQLLNIDSSA-N
Synonym5-[(4-CHLOROANILINO)METHYLENE]-3-(4-CHLOROPHENYL)-4-OXO-1,3-THIAZOLAN-1-IUM-1-OLATE;(5E)-3-(4-chlorophenyl)-5-{[(4-chlorophenyl)amino]methylidene}-4-oxo-1,3-thiazolidin-1-ium-1-olate;4(5H)-Thiazolidinone, 3-(4-chlorophenyl)-5-[[(4-chlorophenyl)amino]methylene]-2,3-dihydro-, 1-oxide
CAS No.338752-82-2

Synthetic Route by SureRoute

1. ACIEFF736 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIEFF736 route product structure diagram
    ACIEFF736338752-82-2
Inquiry

2. ACIEFF736 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYI291 route compound structure diagram
    ACDLYI2912617-79-0 In Stock
  4. Then
  5. ACIEFF736 route product structure diagram
    ACIEFF736338752-82-2
Inquiry

Comments (0)